Gapping up
In reaction to strong earnings/guidance: SPCB +6.6%, RYAAY +5.2%, HLF +2.5%, GOLD +1.3%.
M&A news: ARTC +8% and SNN +0.8%(Smith & Nephew strengthens global sports medicine business through agreement to acquire ArthroCare for $1.7 billion), TWC +2.3% (Charter (CHTR) contemplating increasing bid for Time Warner Cable over $140 per share, according to reports)
A few social media names are seeing early strength: YELP +1.4%, TWTR +1.2%, FB +1.2%, LNKD +0.9%
Other news: GIG +10.4% (announced that its Custom Structured ASIC applications are establishing GigOptix as one the foremost providers of ASICs for cryptocurrency bit mining market), IPCI +8.1% (receives $3.1 mln from Par Pharmaceuticals; first profit-share payment on 15 and 30 mg generic Focalin XR sales), BEAT +5.6% (announces 'significant' patent Litigation Victory and the Acquisition of Mednet Healthcare Technologies), PDLI +4.4% (announces agreement with Genentech and Roche to settle litigation and arbitration; Genentech will pay a fixed royalty rate of 2.125% on worldwide sales of Avastin, Herceptin, Lucentis Xolair, Kadcyla and Perjeta ), NBG +4.3% (still checking for anything specific), CTIC +4.1% (announced that Karen Ignagni has been appointed a Director, effective immediately), TASR +2.9% ( set to join the S&P SmallCap 600), QIHU +2.9% (still checking), ALV +2.6% (still checking), TRP +2% (Final environmental review demonstrates Keystone XL 'should be approved'), NEM +1.8% (still checking), WTW +1.4% (positive Barron's mention), APU +1% (positive MadMoney mention), YRCW +0.5% (YRC Worldwide Successfully Closes $300 Million Debt Reduction), F +0.4% (following positive Barron's mention), GIVN +0.2% (receives FDA clearance for PillCam COLON in patients following incomplete colonoscopy ) .
Analyst comments: PANW +1.8% (upgraded to Outperform from Market Perform at Wells Fargo), PHM +1.6% (upgraded to Positive from Neutral at Susquehanna), COG +1.1% ( upgraded to Overweight from Equal Weight at Barclays), WFM +0.8% (upgraded to Overweight from Neutral at Piper Jaffray), AAL +0.7% ( initiated with a Overweight at Morgan Stanley), GS +0.4% (Goldman Sachs upgraded to Buy from Neutral at Guggenheim)